Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-045920
Filing Date
2006-03-06
Accepted
2006-03-06 13:47:57
Documents
11
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR YEAR ENDED DECEMBER 31, 2005 d10k.htm 10-K 941512
2 FORM OF INDEMNIFICATION AGREEMENT dex108.htm EX-10.8 36518
3 FORM OF CHANGE IN CONTROL SEVERANCE AGREEMENT WITH LAUREN SILVERNAIL dex1017.htm EX-10.17 40364
4 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 680
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1819
6 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 6831
7 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 6948
8 SECTION 906 CERTIFICATION OF CEO dex321.htm EX-32.1 2690
9 SECTION 906 CERTIFICATION OF CFO dex322.htm EX-32.2 2868
10 GRAPHIC g14830g06e72.jpg GRAPHIC 107054
11 GRAPHIC g14830g66j46.jpg GRAPHIC 113688
  Complete submission text file 0001193125-06-045920.txt   1346158
Mailing Address 15295 ALTON PARKWAY IRVINE CA 92618
Business Address 15295 ALTON PARKWAY IRVINE CA 92618 949-788-6000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31255 | Film No.: 06666722
SIC: 2835 In Vitro & In Vivo Diagnostic Substances